Cargando…

A cost/benefit analysis of self-care initiatives in the European Union: who gains, who loses?

Detalles Bibliográficos
Autores principales:	Renner, Anna-Theresa, Bobek, Julia, Ostermann, Herwig, Schneider, Peter, Vogler, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603308/ http://dx.doi.org/10.1186/2052-3211-8-S1-O5

Ejemplares similares

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Governing health professional mobility in the European Union
por: Wismar, Matthias
Publicado: (2014)

China and the European Union in Africa: win–win-lose or win–win-win?
por: Che, Dewei, et al.
Publicado: (2023)

Impact of discounts on medicine prices
por: Schneider, Peter, et al.
Publicado: (2015)

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
por: Vogler, Sabine, et al.
Publicado: (2011)

Ayushman Bharat Initiative (2018): What we Stand to Gain or Lose!
por: Bakshi, Harsh, et al.
Publicado: (2018)

Euro who's who: who's who in the European Communities and in the other European organizations
por: Delta
Publicado: (1991)

Recruitment and retention of health professionals in the European Union: lessons from country experiences
por: Dussault, Gilles
Publicado: (2014)

It’s not who you lose, it’s who you are: Identity and symptom trajectory in prolonged grief
por: Harris, Celia B., et al.
Publicado: (2021)

O032 It's OK to Lose your Head!
por: Omond, S
Publicado: (2023)

Who's who : European Communities and other European Organizations
por: Delta
Publicado: (1986)

Who do treatments work for and why? Understanding treatment-effect mechanisms in stratified medicine
por: Emsley, Richard, et al.
Publicado: (2013)

The European Union Committee of Experts on Rare Diseases (EUCERD): a new committee to help the European Commission advance in the field of rare disease policy
por: Moliner, Antoni Montserrat, et al.
Publicado: (2010)

Who will lose weight? A reexamination of predictors of weight loss in women
por: Teixeira, Pedro J, et al.
Publicado: (2004)

Who's who in the European information world
por: Hidalgo, Ana, et al.
Publicado: (1994)

Teleost innate immunity, an intricate game between immune cells and parasites of fish organs: who wins, who loses
por: Sayyaf Dezfuli, Bahram, et al.
Publicado: (2023)

Randomized controlled trials: who fails run-in?
por: Rees, Judy R, et al.
Publicado: (2015)

Who is responsible for animal welfare? The veterinary answer
por: Algers, Bo
Publicado: (2008)

Who benefits most?
por: Van Diermen, L.
Publicado: (2021)

The growing controversy about growth charts: WHO or regional?
por: Khadilkar, Vaman
Publicado: (2013)

Contributing factors in children who present with calcaneal apophysitis
por: Alicia, James, et al.
Publicado: (2015)

Who Gains Mental Health Benefits from Work Autonomy? The Roles of Gender and Occupational Class
por: Lu, Zhuofei, et al.
Publicado: (2023)

57. Evaluation of the 2019 European Heart Rhythm Association International Consensus Document in Patients with Cardiovascular Implantable Electronic Devices Who Develop Staphylococcus aureus Bacteremia
por: Chesdachai, Supavit, et al.
Publicado: (2021)

Who Called Team Europe? The European Union’s Development Policy Response During the First Wave of COVID-19
por: Burni, Aline, et al.
Publicado: (2021)

Dredging in the Spratly Islands: Gaining Land but Losing Reefs
por: Mora, Camilo, et al.
Publicado: (2016)

72. Massive Weight Gain in People with HIV (PWH) Starting Initial Antiretroviral Therapy (ART): Risk Factors and Predictive Ability of Early Weight Gain
por: Phupitakphol, Tanit, et al.
Publicado: (2021)

OA01.03. Sample size and regions of principally achievable significance in cost effectiveness studies: an example of complementary medicine
por: Ostermann, T, et al.
Publicado: (2012)

Eating and Psychological Profiles of Women with Higher Depressive Symptoms Who Are Trying to Lose Weight
por: Bégin, C., et al.
Publicado: (2012)

Background and features of the WHO hand hygiene self-assessment framework
por: Allegranzi, B, et al.
Publicado: (2011)

S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM WHO 2017 TO WHO 2022 AND ICC 2022): AN EXPANDED ANALYSIS OF 7017 PATIENTS ON BEHALF OF THE INTERNATIONAL CONSORTIUM FOR MDS (ICMDS)
por: Komrokji, Rami S., et al.
Publicado: (2023)

Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities
por: Vogler, Sabine, et al.
Publicado: (2015)

Enriching the evidence base: moving towards full societal costs and benefits
por: Brouwer, Werner
Publicado: (2014)

Can we predict who will complete outpatient therapy for anorexia nervosa?
por: Jordan, Jennifer, et al.
Publicado: (2015)

Alcoholics Anonymous: Who Benefits?
por: Tonigan, J. Scott, et al.
Publicado: (1994)

Policy options to deal with high-cost medicines – survey with European policy-makers
por: Zimmermann, Nina, et al.
Publicado: (2015)

Life Gain in Italian Smokers Who Quit
por: Carrozzi, Laura, et al.
Publicado: (2014)

Chinese vaccine developers gain WHO imprimatur
por: Jia, Hepeng, et al.
Publicado: (2011)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Lose Sleep, Gain Weight: Another Piece of the Obesity Puzzle
por: Spivey, Angela
Publicado: (2010)

Credibility: how leaders gain and lose it, why people demand it
por: Kouzes, James M, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_9ugf3kah1rftutrj14c1rk7pi9